Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04645069
Title ADG126, ADG126 in Combination With Toripalimab, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adagene Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of California Los Angeles Los Angeles California 90095 United States Details
Next oncology San Antonio Texas 78229 United States Details
Southside Cancer Care Centre Miranda New South Wales 2228 Australia Details
Macquarie University Hospital Sydney New South Wales Australia Details
Sunshine Coast University Private Hospital Birtinya Queensland 4575 Australia Details
Cabrini Health Limited Malvern Victoria 3144 Australia Details
One Clinical Research Pty Ltd Nedlands Western Australia 6009 Australia Details
National University Hospital Singapore 119074 Singapore Details
National Cancer Centre Singapore Singapore 169610 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field